JAMA Clinical Reviews

Author interviews that explore the latest clinical reviews.

Episodes

Total: 424

The human microbiome appears to influence risk for development and progression of cancer and respons

Endometriosis, a common cause of pelvic pain, affects approximately 10% of reproductive-age females.

What is the single most important thing to recognize when communicating with families about vaccines

Non-cystic fibrosis (CF) bronchiectasis, which affects approximately a half million people in the US

A JAMA Clinical Guidelines Synopsis summarizes the Endocrine Society’s most recent recommendations o

What are 3 fundamental communication skills needed when discussing surgery with patients? Author Lau

Small cell lung cancer (SCLC) is a smoking-related malignancy that presents at an advanced stage in

Polycystic kidney disease is the most common genetic kidney disease worldwide and is characterized b

Chronic myeloid leukemia is a myeloproliferative neoplasm that affects approximately 5 million peopl

Interview with Tumaini Rucker Coker, MD, MBA, USPSTF member and coauthor of Screening for Food Insec

Prostate cancer is the most common nonskin cancer in men in the US and the second most common cancer

A recent JAMA article reviews the 3 most common eating disorders, their risk factors, diagnosis and

In 2024, the American Law Institute revised the legal standard for assessing medical negligence. Aut

Out-of-hospital cardiac arrest in apparently healthy adults younger than 40 years ranges from 4 to 1

Guidelines from the American Thoracic Society report on the value of pulmonary rehabilitation for pe

Essential thrombocythemia, a clonal myeloproliferative neoplasm with excessive platelet production,

Interview with Esa M. Davis, MD, MPH, USPSTF member and coauthor of Screening for Osteoporosis to Pr

NIH'S policies, programs, and research funding fill gaps in knowledge about women’s health. Janine A

JAMA Deputy Editor Mary McDermott, MD, and JAMA Deputy Editor Kristin Walter, MD, MS, highlight thei

Chronic kidney disease develops among 30% to 40% of people with type 1 or type 2 diabetes during the